More on EWTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.7 Score)

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Edgewise Therapeutics Inc. (NQ:EWTX)
Delayed: 27.82 -0.57 (2.01%)
Prev. Close $28.39  
Open$28.08 
52 Wk High$ 
52 Wk Low$ 
Day High$28.08 
Day Low$26.82 
P/E N/A  
EPS$ 
Volume1,170,126 

Friends, Peers and Foes (?): CYTK, ACAD, BCRX, CATX, CDTX (more...)

Mar 4, 2026 08:01 AM Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026
Mar 3, 2026 08:01 AM Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference
Mar 2, 2026 09:30 AM Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Feb 26, 2026 04:02 PM Edgewise Therapeutics (EWTX) PT Raised to $45 at Evercore ISI
Feb 26, 2026 02:31 PM Raymond James: 'we continue to see a highly attractive long-term risk/reward skew for EWTX'
Feb 26, 2026 09:50 AM Edgewise Therapeutics (EWTX) PT Raised to $25 at Stifel
Feb 26, 2026 08:06 AM Form 10-K Edgewise Therapeutics, For: Dec 31
Feb 26, 2026 08:06 AM Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 3c
Feb 26, 2026 08:02 AM Form 8-K Edgewise Therapeutics, For: Feb 26
Feb 26, 2026 08:01 AM Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs
View All Articles

Entities mentioned with EWTX

View All Entities